Stockalyze
Example report. Sign up to run the same analysis on any ticker.
INTC logoINTCEquity research

Report date: 2026-11-17

$52.92-2.80 (-5.03%)Live · delayed quote, informational only

Analysis focus

Provide a balanced, comprehensive analysis: fundamentals and valuation, the Wall Street view, technical posture, and the key forward risks and catalysts.

Summary

Intel's Q3 2026 results were mixed once one-time items are normalized. Revenue rose 21% year over year to $16.51B from $13.65B. Data Center and AI drove the growth, up 78% to $7.3B, while Client Computing and Physical AI fell 5% to $8.1B [2][8]. Non-GAAP EPS was $0.52, up from $0.23 and above Intel's own $0.38 guidance, though revenue came in slightly below the $16.56B consensus MarketBeat cites [8]. GAAP EPS fell to $0.60 from $0.90, but that comparison is distorted by one-time items on both sides. The prior-year quarter included a $5,452M divestiture gain, mostly from Altera. Q3 2026 GAAP results were lifted by an Escrowed Shares mark-to-market gain and $330M of net equity-investment gains, which is why GAAP EPS was above non-GAAP [13][18]. Non-GAAP EPS of $0.52 is the better measure of operating results. Over nine months, a $12,614M Escrowed Shares loss and $3,969M of restructuring produced an $11,609M net loss [13]. The outlook is the main problem: Q4 guidance calls for $15.0B to $16.0B of revenue, a 38.0% non-GAAP gross margin (down from 44.1%) and $0.25 of non-GAAP EPS (down from $0.52) [9]. The balance sheet is a support. At quarter end Intel held about $54.0B of cash and investments against about $50.1B of debt, a small net cash position. Q3 operating cash flow was $5.08B, capex $4.22B and adjusted free cash flow $1.64B. However, shares outstanding rose to 5,310M from 4,994M after a $22.6B net equity offering, which dilutes per-share figures [5]. At $55.47 (market cap about $294.8B, EV about $290.6B), trailing P/E is not meaningful because trailing earnings are negative. Forward P/E is 39.85x, P/B 2.56x, P/S 4.92x and EV/EBITDA 15.18x [3]. Against AMD, Intel trades at a slight premium on forward P/E (AMD 33.50x) but at a deep discount on EV/EBITDA (AMD 73.63x), P/B (12.09x) and P/S (18.20x). AMD's TTM free cash flow of $7.06B is also well above Intel's $3.77B [4]. Against its own history, EV/EBITDA is close to FY2025's 15.68x but well above FY2021-FY2022 (6.27x-7.37x). P/B is the highest since at least FY2021, partly because of the equity raise. Forward P/E is below FY2025's 85.44x but well above FY2021-FY2022 (14.22x-18.19x) [21]. Intel pays no dividend [14]. The Wall Street view has moved to cautious. The consensus is Hold: of 49 analysts, 12 rate it Strong Buy, 2 Buy, 34 Hold, 0 Sell and 1 Strong Sell, and other aggregators also show Hold [1]. Ratings and targets were cut widely after Q3. Bank of America downgraded to Neutral and cut its target from $145 to $100, then to $80 [15]. Citi kept its Buy rating but cut its target from $130 to $100 [7]. Barclays and RBC both rate Intel Hold with $75 targets [7]. Roth downgraded to Neutral with a cut from $120 to $70, Freedom Broker moved to Hold at $90, and Susquehanna cut to $105 and later reportedly to $75 [16]. The average target of $90.65 (median $86, range $63-$160) sits well above the price, and the stock is about 12% below even the lowest target. This suggests many targets have not caught up with the sell-off [6]. The cautious case rests on several points: the sharp Q4 margin and EPS step-down [9], a reported two-week Kiryat Gat fab shutdown estimated to cost about $300M of Q4 revenue and about 200bp of gross margin, management's expectation of double-digit PC market contraction through mid-2027, a new securities class action naming the CEO and CFO [20], share dilution [5], and a forward P/E above AMD's [4]. The more patient case points to strong Data Center and AI growth [2], net cash [5], EV/EBITDA far below AMD's [4], and price targets that are still above the price even after the cuts [6][7][15]. Technically, the stock is in a clear downtrend. The day after earnings it reportedly fell about 28.6% to roughly $65.76, described as its worst day since 1974, and it kept falling to $55.47 by Nov 16 [10]. As of Nov 13 it was down 33.60% over one month [17]. The price is far below the 50-day moving average ($94.17) and the 200-day ($87.44). The 14-day RSI is 29.86 and the 5-year beta is 2.43 [19]. Other aggregators put RSI between about 28.8 and 32.42, and MACD (12,26,9) is at -0.260, a sell signal [12]. TipRanks' moving-average tally is 11 Bearish to 1 Bullish [22]. Support is cited in the $52.25 to $54.00 zone [23]. The 52-week range is $32.89 to $142.35, and the stock is still up roughly 47.6% to 56% over a year, depending on the source [11][19]. Key forward risks are delivery against the weak Q4 guide [9], the fab-outage, PC-demand and litigation headwinds [20], and high volatility [19]. Possible catalysts are continued Data Center and AI momentum [2], a reset of analyst targets toward the current price [6], and the oversold readings that Investtech notes can come before a technical rebound [12]. Taken together, the evidence shows real revenue growth and a solid balance sheet set against a sharp margin reset and weak near-term sentiment. Readers should weigh these themselves; this report makes no recommendation.

Findings (23)

As of mid-November 2026, Wall Street's consensus rating on Intel is Hold. Of the 49 analysts S&P Global tracks, 12 rate it Strong Buy, 2 Buy, 34 Hold, 0 Sell and 1 Strong Sell; other aggregators also show Hold (MarketBeat with 51 analysts, Public.com with 35).

High confidence

StockAnalysis gives the 12/2/34/0/1 breakdown and a 'Hold' consensus from 49 analysts per S&P Global. The search excerpts show MarketBeat reporting a 'Hold' average from 51 analysts and Public.com a Hold consensus from 35 analysts as of Nov 16, 2026.

Intel reported Q3 2026 revenue of $16.51 billion (up 21% from $13.65 billion a year earlier), GAAP diluted EPS of $0.60 (down from $0.90) and non-GAAP EPS of $0.52 (up from $0.23); GAAP gross margin was 43.0% and non-GAAP was 44.1%.

High confidence

Intel's Q3 2026 earnings release, also filed as an 8-K exhibit, gives these revenue, EPS and margin figures for the quarter ended September 26, 2026. The segment detail in the release shows Data Center and AI revenue up 78% to $7.3 billion and Client Computing and Physical AI down 5% to $8.1 billion.

As of the November 16, 2026 close, INTC traded at $55.47 ($53.63 after hours), with a market cap of about $294.8 billion and an enterprise value of about $290.6 billion. Trailing P/E is not meaningful because trailing earnings are negative; forward P/E is 39.85x, P/B 2.56x, P/S 4.92x and EV/EBITDA 15.18x.

High confidence

Stockanalysis.com's statistics page, dated the Nov 16, 2026 close, gives these figures. Value Research Online separately showed about $58.61 and a market cap of about $299 billion on Nov 13, with no P/E because trailing earnings are negative, which is consistent with the further fall on Nov 16.

Peer comparison: AMD trades at much richer multiples than Intel, with a 33.50x forward P/E (Intel 39.85x), EV/EBITDA of 73.63x (Intel 15.18x), P/B of 12.09x (Intel 2.56x) and P/S of 18.20x (Intel 4.92x). AMD's TTM free cash flow of $7.06 billion is also higher than Intel's $3.77 billion, and neither company pays a dividend.

High confidence

Both statistics pages are dated the Nov 16, 2026 close and give these multiples and free cash flow figures. On a forward basis Intel trades at a slight premium to AMD, while on trailing EBITDA and book value it trades at a deep discount.

At September 26, 2026, Intel held about $54.0 billion of cash and short-term investments ($21.8B cash plus $32.2B investments) against about $50.1 billion of debt ($3.8B short-term plus $46.3B long-term), a small net cash position. Q3 operating cash flow was $5.08 billion and capex $4.22 billion; Intel's adjusted free cash flow measure was $1.64 billion. Shares outstanding rose to 5,310 million from 4,994 million at the end of 2025 after a $22.6 billion net equity offering.

High confidence

The release's balance sheet and cash flow statement give the cash, investments, debt, operating cash flow, capex, adjusted FCF, share count and equity offering proceeds. Stockanalysis independently shows total debt of $50.13B, cash of $54.01B and TTM FCF of $3.77B. The 6% increase in share count dilutes per-share figures.

The consensus 12-month price target averages $90.65 with a median of $86, ranging from $63 to $160. Intel closed at $55.47 on Nov 16, 2026, about 12% below even the lowest target, which suggests many targets have not caught up with the sell-off.

Medium confidence

StockAnalysis shows the $63/$90.65/$86/$160 targets and a $55.47 close (down 7.02% on Nov 16), but its targets were last updated Nov 12. Other trackers report higher averages, likely because they weight older targets more: MarketBeat $96.93, Public.com $94.89, and ChartMill $117.15 as of Oct 30. Medium confidence because of this spread.

Among other major banks, Citi kept its Buy rating but cut its target from $130 to $100, about 80% above the $55.47 price. Barclays (Thomas O'Malley, Nov 5) and RBC Capital (Srini Pajjuri, Nov 10) both rate Intel Hold with $75 targets, about 35% above the price.

High confidence

StockAnalysis's recent-actions table lists Citi (Atif Malik) Buy $130 to $100 on Nov 2, Barclays Hold $75 on Nov 5, and RBC Hold $75 on Nov 10. MarketBeat dates the Citi cut to Oct 30. The percentages compare each target with StockAnalysis's Nov 16 close.

In Q3 2026 Intel reported revenue of $16.5B, up 21% year over year from $13.7B, and non-GAAP EPS of $0.52, up from $0.23 and above its own $0.38 guidance. GAAP EPS fell to $0.60 from $0.90 because Q3 2025 included a one-time $5.45B gain, mainly from the Altera divestiture.

High confidence

The Q3 2026 earnings release filed with the 8-K reports $16.5B revenue, GAAP EPS of $0.60 vs $0.90, non-GAAP EPS of $0.52 vs $0.23, Data Center & AI revenue of $7.3B (+78%) and Client revenue of $8.1B (-5%). Q3 2026 GAAP results also include one-time items that should be normalized: $330M of net equity-investment gains and an escrowed-shares mark-to-market gain worth $120M in the diluted EPS calculation. MarketBeat puts revenue at $16.51B against a $16.56B consensus, a slight miss.

Intel's Q4 2026 guidance is weaker than Q3: revenue of $15.0B to $16.0B, non-GAAP gross margin of 38.0% (down from 44.1% in Q3), and non-GAAP EPS of $0.25 (down from $0.52).

High confidence

The 8-K release gives the Q4 outlook: $15.0B to $16.0B revenue, 37.1% GAAP and 38.0% non-GAAP gross margin, and $0.10 GAAP and $0.25 non-GAAP EPS. A secondary summary said the guide includes about $300M of revenue and 200bp of margin impact from a Fab 28 incident, but the release does not mention this, so that attribution is unverified.

The day after earnings, Intel shares fell about 28.6% to roughly $65.76, reported as their worst day since July 1974. They kept falling to $55.47 by Nov 16, about 16% below that post-earnings level, which leaves the stock in a clear short-term downtrend.

Medium confidence

Benzinga's headline reports a 28% drop and the worst day since 1974, and Tech-Insider's headline gives a 28.6% fall to $65.76. Tech-Insider is a lower-quality outlet. StockAnalysis shows the $55.47 close on Nov 16, and MarketBeat reported a further 8.8% drop after another downgrade on Nov 2. Medium confidence because the 28.6% and $65.76 figures come from headlines and were not checked against exchange data.

INTC is about 58% below its 52-week intraday high of $142.35 set on June 30, 2026, while its 52-week low is $32.89; quote pages show a 1-year gain of about 47.6%, and 24/7 Wall St. put the year-to-date gain at 47.83% as of November 11, 2026.

Medium confidence

24/7 Wall St. (November 3) reported the stock 57.9% below its 52-week high and gave the $142.35 high and $32.89 low; Fox Business shows a 32.89–142.34 range and a 1-month change of -46.25%. The 47.6% 1-year figure comes from undated quote pages, so its reference date is uncertain, and no sourced 6-month return was found (mid-May 2026 price not verified).

Momentum readings were near oversold in mid-November 2026: RSI(14) was reported at 28.8 on November 10, 32.42 on TipRanks, and 30.66 on November 16, with MACD(12,26,9) at -0.260, a sell signal.

Medium confidence

Several aggregators put RSI(14) between about 28.8 and 32.4, and Investtech notes RSI below 30 after weeks of falling prices, which can come before a technical rebound. The sources disagree on how to read these levels: TipRanks calls 32.42 'Neutral' and TradingKey calls 30.66 'neutral'.

Q3 2026 GAAP EPS ($0.60) was higher than non-GAAP EPS ($0.52) because of non-operating items: a $1,005 million mark-to-market gain on Escrowed Shares and $330 million of net equity-investment gains. The prior-year GAAP figure of $0.90 was boosted by a $5,452 million divestiture gain, mostly from Altera, so the 33% year-over-year GAAP EPS decline overstates how much the underlying business weakened.

High confidence

The GAAP-to-non-GAAP reconciliation in the release lists the Escrowed Shares gain ($1,005M in net income), the equity-investment gains ($330M), restructuring ($54M) and the prior-year Altera divestiture gain ($5,452M). Over the first nine months of 2026, the same Escrowed Shares line was a $12,614 million loss and restructuring was $3,969 million, which produced a nine-month net loss of $11,609 million.

Intel pays no dividend. Its yield was 1.85% in FY2024 and 5.54% in FY2022, and none is shown for FY2025 or currently. The Wall Street view is mostly Hold: stockanalysis shows a 'Hold' consensus from 49 analysts with an average target of $90.65, and 24/7 Wall St. reported on Nov 3 an average target of $101.02 with 1 Strong Buy, 14 Buy, 32 Hold, 1 Sell and 1 Strong Sell.

Medium confidence

The ratio history shows dividend yields through FY2024 and none for FY2025 or the current period, and the statistics page lists the dividend as n/a. The two aggregators' consensus targets differ ($90.65 vs $101.02) because they cover different analyst sets and dates, and several targets probably predate the post-earnings drop.

Bank of America's Vivek Arya downgraded Intel to Neutral after Q3 and cut the target from $145 to $100, then cut it again to $80. The $80 target is about 44% above the $55.47 close on Nov 16.

Medium confidence

Benzinga's search excerpt reports the Oct 30 downgrade with the $145-to-$100 cut. StockAnalysis lists BofA reiterating Hold with a $100-to-$80 cut on Nov 12, and GuruFocus confirms the $80 Neutral target. Medium confidence because the sources disagree on the date of the $80 cut (Oct 30 vs Nov 12), and the Benzinga page could not be fetched directly.

Smaller firms also turned cautious after Q3. On Oct 30 Roth Capital downgraded Intel to Neutral and cut its target from $120 to $70, and Freedom Broker moved to Hold with a target cut from $100 to $90. Susquehanna kept its Neutral rating and cut its target from $115 to $105, with a later report showing a further cut to $75. The searches found no Goldman Sachs, Morgan Stanley or JPMorgan actions in the last 90 days.

Medium confidence

MarketBeat alerts report the Roth downgrade ($120 to $70) and the Freedom Broker and Susquehanna cuts, and a Benzinga table excerpt shows Susquehanna at $75. Medium confidence because these figures come from search-result excerpts, not fetched pages, and the gap for Goldman, Morgan Stanley and JPMorgan is a limit of the search, not proof they made no change.

INTC closed at $59.66 on November 13, 2026, down 2.52% from $61.20 the previous day; it gained 6.01% that week but was down 33.60% over one month, and a TradingKey report says it opened another 4.63% lower on November 16, 2026.

Medium confidence

The JournalArta week-ahead piece gives the $59.66 close and the weekly and monthly changes, and TradingKey's November 16 note reports the 4.63% lower open. Both are automated secondary commentary sites, the JournalArta page could not be fetched directly (HTTP 403), and no November 17 close was found.

Intel's Q3 2026 revenue rose 21% year over year to $16.5B, with non-GAAP EPS of $0.52 and non-GAAP gross margin of 44.1%; GAAP EPS of $0.60 was boosted by one-time items, including $330M of net gains on equity investments and a $120M mark-to-market gain on a derivative liability tied to escrowed shares.

High confidence

Intel's October 29, 2026 Business Wire release gives the revenue, EPS and margin figures and lists the $330M equity gains, the $120M derivative mark-to-market gain and $54M of restructuring charges. Normalized for these non-operating gains, the non-GAAP $0.52 better reflects operating results than GAAP $0.60.

Technically, the shares are deeply oversold after the post-earnings sell-off. The $55.47 price is far below the 50-day moving average ($94.17) and the 200-day ($87.44), the 14-day RSI is 29.86, and the 5-year beta is 2.43. The stock is still up about 56% over 52 weeks.

Medium confidence

Stockanalysis.com's statistics page gives the moving averages, RSI, beta and 52-week change as of Nov 16, 2026. 24/7 Wall St. reported on Nov 3 that Intel had lost more than half its value from its peak; the moving averages are secondary-source figures and may be computed differently elsewhere.

Other headwinds cited in mid-November 2026 include a two-week shutdown at Intel's Kiryat Gat fab, estimated to cut about $300M from Q4 revenue and about 200 basis points from gross margin; management's expectation of double-digit PC market contraction through mid-2027; a $23B equity offering; and a new securities class action naming the CEO and CFO. Bank of America cut its target to $80 from $100, against an average analyst target of $91.99.

Medium confidence

TradingKey's November 16 note lists the Kiryat Gat impact, the PC outlook, the class action, the BofA target cut and the $91.99 average target (high $160, low $63). 24/7 Wall St. put the average target at $101.02 on November 3, with 15 Buy or Strong Buy, 32 Hold and 2 Sell or Strong Sell ratings. These are secondary sources and the fab and lawsuit details were not checked against primary filings; no peer valuation comparison was sourced in this search budget.

Compared with its own history, Intel's current EV/EBITDA of 15.18x is close to its FY2025 level (15.68x) and above FY2021-FY2022 (6.27x-7.37x). Its P/B of 2.56x is the highest since at least FY2021 (range 0.83x-2.19x). Its forward P/E of 39.85x is below FY2025's 85.44x but well above FY2021-FY2022 (14.22x-18.19x).

Medium confidence

Stockanalysis.com's annual ratio history lists FY2021-FY2025 and current values for these multiples. Part of the jump in P/B reflects the $23 billion equity raise and higher share count, not only the share price.

INTC is trading below its 20-day and 50-day moving averages, and TipRanks' moving-average consensus was 11 Bearish, 0 Neutral and 1 Bullish; no sourced 200-day moving average value was found, though a roughly 58% drawdown from the June 2026 peak makes a price below the 200-day likely.

Low confidence

JournalArta says the stock enters the November 16–20 week below both its 20-day and 50-day averages, and TipRanks gives the 11/0/1 moving-average tally. StockInvest.us rates the technical score -4.22 on a -10 to +10 scale. No source gave exact moving-average values, so the 200-day position is an inference, not a cited figure.

Sources disagree on key levels: JournalArta cites support near $52.25 and resistance around $95.53, while Investtech identifies $54.00 as a former resistance level now acting as support.

Low confidence

Both levels come from secondary or automated technical commentary rather than primary data. The $52–54 support zone is the more consistent reading across the two sources; the $95.53 resistance sits far above the current price.

Sources (34)

Caveats

Time-sensitive data: prices and multiples are as of the Nov 16, 2026 close ($55.47, with $53.63 after hours) [3]. No Nov 17 close was found [17], and a 7% one-day move [6] shows how quickly these figures can go stale. Consensus price targets vary widely between trackers and dates: $90.65 [6], $91.99 [20], $94.89 to $96.93 [6], $101.02 as of Nov 3 [14] and $117.15 as of Oct 30 [6]. Several targets likely predate the post-earnings sell-off, and StockAnalysis's targets were last updated Nov 12. The sources also conflict on the Q3 Escrowed Shares gain. The reconciliation lists $1,005M in net income [13], while other findings describe a $120M figure in the diluted EPS calculation or for a related derivative liability [8][18]. Readers should check the primary reconciliation. The Fab 28/Kiryat Gat impact (about $300M of revenue and about 200bp of margin) comes only from secondary sources and is not mentioned in Intel's release [9][20]. The class action and the PC-contraction outlook were also not checked against primary filings [20]. The date of BofA's cut to $80 is uncertain (Oct 30 vs Nov 12) [15]. The Roth, Freedom Broker and Susquehanna actions come from search excerpts, not fetched pages. No Goldman Sachs, Morgan Stanley or JPMorgan actions were found, which reflects the limits of the search, not proof that none occurred [16]. The 28.6% one-day drop and $65.76 price come from headlines, including a lower-quality outlet, and were not checked against exchange data [10]. The 58% drawdown from the 52-week high was measured on Nov 3, and the gap has widened since [11]. The 1-year return differs by source (about 47.6% vs about 56%), the 47.6% figure has an uncertain reference date, and no 6-month return was sourced [11][19]. Sources disagree on whether RSI readings near 30 count as oversold or neutral [12]. One finding says no 200-day average value was sourced [22], while StockAnalysis gives $87.44 [19]; moving averages may be computed differently across sources. Technical levels come from automated secondary commentary [17][22][23]. Valuation multiples come from a secondary aggregator rather than primary filings. The peer comparison uses only AMD, and the earnings basis behind the forward P/E is not specified [3][4]. The jump in P/B partly reflects the equity raise rather than the share price alone [21]. Not covered: foundry-business economics, segment operating margins, management commentary beyond the numeric guidance, competitive market-share data, full-year 2027 consensus estimates, and Intel's ownership structure and strategic investors. This report is informational and is not investment advice.

This report is for informational purposes only and is not investment advice. No buy / sell / hold recommendation is made or implied.

More research reports

Recent reports from the same pipeline. See all examples

Want this on your watchlist?

Add your own focus, pick a delivery speed, and get a source-verified report like this one.